Anticoagulation in pulmonary arterial hypertension: Contemporary data from COMPERA registry

The use of anticoagulant therapy in patients with pulmonary arterial hypertension (PAH) has been controversial for decades. Recommendations for anticoagulation in these patients are often derived from small, retrospective, and single centre studies without any placebo-controlled randomized study. Fu...

Descripción completa

Detalles Bibliográficos
Autor principal: Said, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2014
Materias:
Lessons from the Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220434/
https://www.ncbi.nlm.nih.gov/pubmed/25405178
http://dx.doi.org/10.5339/gcsp.2014.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220434/
https://www.ncbi.nlm.nih.gov/pubmed/25405178
http://dx.doi.org/10.5339/gcsp.2014.25

Ejemplares similares